CION Ameerpet
Staging Explained · Reviewed by CION Oncologists · NABH Accredited
Stage 1 Endometrial Cancer — Still Inside the Uterus
Stage 1 means the cancer is confined to the body of the uterus. It has not reached the cervix, the lymph nodes, or anything beyond — it is where it started. This is the stage at which most endometrial cancer is found, for a reason worth knowing: this cancer announces itself early, through abnormal bleeding, at a point when it is still contained. For most women at this stage the treatment is an operation, and for a substantial proportion nothing follows it. That is an unusual sentence in oncology, and it is a genuine feature of this disease rather than reassurance.
- Confined to the uterus — no cervical stromal spread, no node involvement, nothing beyond the organ
- The commonest stage at diagnosis — because bleeding brings women in while the disease is still contained
- Surgery is the treatment — removing the uterus is usually curative in itself at this stage
- Often nothing follows — many low-risk stage 1 tumours need no radiation and no drug treatment
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
What Stage 1 Actually Means
The uterus has two relevant layers. The endometrium is the lining, where this cancer starts. Beneath it is the myometrium, the thick muscular wall that makes up most of the organ. Stage 1 means the tumour is somewhere within those two layers and has gone no further.
Within stage 1, the substages turn mainly on one measurement: how far into the muscle wall the tumour has grown.
- Confined to the lining, or invading less than halfway into the muscle. The most favourable position. Historically labelled stage IA, and in the current system subdivided further according to type and molecular group.
- Invading half the muscle wall or more. Historically stage IB. The tumour is still inside the uterus, but deeper invasion is associated with a higher chance that cells have reached the lymph nodes, which is why it changes what is offered after surgery.
- Nothing beyond the uterine body. If the tumour has grown into the supporting tissue of the cervix, it is no longer stage 1 — see stage 2. If nodes are involved, it is stage 3.
One point of genuine confusion: FIGO revised this staging system in 2023, and the new version subdivides stage 1 more finely, bringing in histological type, lymphovascular invasion and molecular group. Some units still report using the 2009 version. If your report says IA or IB and a relative’s says IA1 or IC, neither is wrong — they are different editions. See FIGO staging explained.
Did You Know? Endometrial cancer is one of the few cancers that is usually caught early, and it is not by luck or screening — there is no screening test for it. It is because the uterus lining bleeds when something is wrong with it, and bleeding after the menopause is alarming enough that most women act on it. United States registry data show that around two thirds of endometrial cancers are diagnosed while still confined to the uterus, and that the great majority of women in that group are alive five years later. The corollary matters just as much: the women who present late are usually the ones whose bleeding was dismissed, or who had no bleeding at all. Sources: SEER (Surveillance, Epidemiology and End Results) Program registry data, US National Cancer Institute; FIGO staging for cancer of the endometrium; NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Why Two Women With Stage 1 Get Different Treatment
This surprises people, and it is the most useful thing to understand about early endometrial cancer. Stage 1 is not one situation — it is a range, and what follows surgery is decided by four other findings on the same report.
| What is assessed | Why it changes the plan |
|---|---|
| Depth of muscle invasion | The strongest single predictor within stage 1 of whether cancer has reached the lymph nodes. Less than half the wall thickness and more than half are treated as meaningfully different situations. |
| Grade | How abnormal the cells look. A Grade 3 stage 1 tumour is watched and treated more carefully than a Grade 1 one, even though both are confined to the uterus. See endometrial cancer grades. |
| Lymphovascular space invasion | Whether tumour cells are seen inside the small vessels in the uterine wall. Substantial involvement raises the risk category on its own, and is one of the commonest reasons an otherwise low-risk stage 1 tumour is offered radiation. |
| Histological type | Serous, clear cell and carcinosarcoma behave more aggressively than the common endometrioid type and are managed more intensively even at stage 1. See Type 2 endometrial cancer. |
| Molecular group | Now built into staging. A POLE-mutated tumour does well even when it looks aggressive and may warrant less treatment; a p53-abnormal tumour is treated as high risk regardless of stage. See MMR and MSI testing. |
What this means in practice: “stage 1” on its own does not tell you whether you will need radiation. If you have been given a stage but not the other four findings, ask for them — they are on the same pathology report, and together they are what the tumour board actually discusses.
Been Told It Is Stage 1?
Bring everything you have. Forty-five minutes is enough to read the stage alongside the grade, the invasion depth and the markers, and say what should reasonably follow.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Caught at Stage 1, This Is a Highly Treatable Cancer
The decisions that matter now are about how much treatment is enough — and how much would be more than you need.
What Treatment Looks Like at Stage 1
Surgery first, in nearly every case. What happens after it is the real question, and for many women the honest answer is nothing.
Always
Hysterectomy
Removal of the uterus and cervix, usually keyhole or robotic. At stage 1 the operation is frequently the whole of the treatment. See what to expect.
Usually
Tubes and Ovaries
Removed in most women, and the decision is weighed separately in younger women because of surgical menopause. See why it is done.
Often
Sentinel Node Mapping
Identifies the first nodes the uterus drains to and samples those, rather than removing many. Same staging information, far less risk of leg lymphoedema.
Sometimes
Vault Brachytherapy
A short internal radiation course aimed at the top of the vagina, where recurrence most often appears. Few sessions, mostly well tolerated. See the experience.
Less often
Pelvic Radiation
Reserved for higher-risk stage 1 — deep invasion with high grade, or substantial vessel involvement. See when it is needed.
Uncommon
Drug Treatment
Rarely part of stage 1 care, and generally confined to aggressive histological types. If it has been proposed for a low-grade stage 1 tumour, ask what is driving that.
The decision most stage 1 patients face
Do You Need Anything After the Operation?
This is where stage 1 care is genuinely decided, and where a good conversation matters more than a good scan. The honest position is that for a large group of women, the answer is no.
Low-risk stage 1: surgery alone is standard
A Grade 1 or 2 endometrioid tumour, invading less than half the muscle wall, with no substantial lymphovascular invasion, is low risk. Guidance across NCCN and the European groups supports surgery alone with no radiation for this group: the risk of recurrence is low enough that treating everybody would expose many women to side effects to benefit very few. If you are in this group and have been offered radiation anyway, it is entirely reasonable to ask what specifically about your case takes you outside the low-risk definition.
Intermediate risk: vault brachytherapy is the usual offer
Deeper invasion, or a higher grade, or age and other factors moving the balance, brings a woman into an intermediate group where the commonest recommendation is vaginal vault brachytherapy. The reasoning is specific: when early endometrial cancer comes back, it most often comes back at the vaginal vault, and a short internal radiation course targeted there reduces that risk substantially with far fewer side effects than radiating the whole pelvis. It is typically a small number of outpatient sessions.
High-intermediate and high risk: pelvic radiation enters the conversation
Where several risk factors coincide — deep invasion together with high grade, or substantial lymphovascular space invasion — treating the wider pelvis rather than only the vault becomes the question. The benefit is a lower risk of recurrence in the pelvic nodes; the cost is a longer course and a greater chance of bowel, bladder and lymphoedema effects. This is a genuine trade-off, and the right answer differs between women with the same pathology. See the adjuvant decision.
Aggressive histological types are treated differently at any stage
Serous carcinoma, clear cell carcinoma and carcinosarcoma do not follow the pattern above. Even confined to the uterus they carry a higher risk of spread within the abdomen, and treatment after surgery — often including chemotherapy — is considered for them at stage 1 where it would not be for an endometrioid tumour with the same measurements. If your report names one of these, the stage number alone will understate the plan. See uterine serous carcinoma.
Molecular group can move the answer in either direction
This is the newest part of the conversation and the one most likely to differ from what a woman reads online. A POLE-mutated stage 1 tumour behaves very favourably even at Grade 3, and European guidance supports omitting treatment that the grade alone would have prompted. A p53-abnormal tumour is treated as high risk even where the stage and invasion look modest. Mismatch repair deficiency additionally identifies who should be offered Lynch syndrome counselling, which has implications for the whole family.
Your own weighing of it counts
Where the absolute benefit of adding radiation is small — a few percentage points of recurrence risk — the decision legitimately involves what you think about those few points against several weeks of treatment and its lasting effects on bowel, bladder and sexual function. Some women want everything that might help; others decline a marginal benefit clearly and reasonably. Neither is the wrong answer, and a tumour board that presents the numbers rather than the conclusion is doing its job properly.
Want a Second View on Whether You Need Treatment After Surgery?
This is the commonest question at stage 1 and the one most worth a second opinion. Bring the pathology and we will go through it properly. The opinion is free.
What the Outlook Data Actually Says
Survival figures are the first thing people search for and the thing most likely to mislead them, so it is worth being precise about what they are.
Registry data from the United States show that endometrial cancer confined to the uterus at diagnosis has a five-year relative survival in the region of 95 per cent — among the most favourable figures in solid tumour oncology. Indian registry data on endometrial cancer specifically is far more limited, which is why we do not publish a CION endometrial survival figure: we would rather say the data is thin than print a number we cannot stand behind.
- These are group statistics, not predictions. A 95 per cent figure describes what happened to a large population of women diagnosed years ago. It does not tell you what will happen to you, and no honest oncologist will convert it into a personal number.
- They lag behind current treatment. Five-year survival data necessarily describes women treated at least five years ago, before molecular classification was in routine use and before current surgical practice. If anything, they understate the present position.
- Relative survival is not the same as cure. It compares women with the diagnosis against women of the same age without it. It is the right measure for comparing groups and the wrong one for answering “am I cured”.
- Within stage 1 there is still a range. A Grade 1 tumour with minimal invasion and a Grade 3 tumour invading deeply are both stage 1 and do not carry the same outlook. See survival by stage for how to read these figures properly.
For what happens in the years after treatment — the follow-up schedule, and what recurrence would look like if it happened — see endometrial cancer recurrence and life after treatment.
Why Stage 1 Deserves a Careful Team, Not a Casual One
Early cancer is where over-treatment does the most avoidable harm — and where getting it right is most achievable.
Tumour board for every diagnosis
Sentinel node mapping where it fits
Vault brachytherapy on site
MMR / MSI testing as standard
Named MCh surgical oncologists
Decisions for healing, not billing
Take The Next Step
Early Is the Best Place to Be Standing
The question now is what treatment is genuinely needed, and what would be more than enough. Let us go through it with you.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Stage 1 Endometrial Cancer — Frequently Asked Questions
What does stage 1 endometrial cancer mean?
It means the cancer is confined to the body of the uterus. It has not grown into the supporting tissue of the cervix, has not reached the lymph nodes, and has not spread anywhere else. Within stage 1, the substages depend mainly on how far the tumour has grown into the myometrium — the thick muscular wall beneath the lining. Disease confined to the lining or invading less than halfway into that wall is the most favourable position; invasion of half the wall or more is still stage 1 but carries a higher chance that cells have reached the lymph nodes. Note that FIGO revised this staging system in 2023 and subdivides stage 1 more finely than the older version, so reports from different units can look different without either being wrong.
Will I need radiation after surgery for stage 1?
Not necessarily, and for a substantial group of women the answer is no. If the tumour is Grade 1 or 2, endometrioid in type, invades less than half the muscle wall and shows no substantial lymphovascular invasion, that is classed as low risk and international guidance supports surgery alone. Vaginal vault brachytherapy — a short internal radiation course aimed at the top of the vagina, where early recurrences usually appear — is the commonest recommendation for the intermediate-risk group. Radiation to the whole pelvis is reserved for higher-risk cases where several factors coincide. If radiation has been proposed and you were told your tumour was low risk, it is fair to ask what specifically moved you out of that category.
Can stage 1 endometrial cancer be cured?
For most women at this stage, the operation removes all of the cancer and no further treatment is needed — which is as close to cure as oncology gets, though doctors are usually careful with the word. Registry data from the United States put five-year relative survival for endometrial cancer confined to the uterus at around 95 per cent. Those are group figures describing women diagnosed years ago, not a prediction for any individual, and they necessarily lag behind current practice. Within stage 1 there is still a range: a Grade 1 tumour with minimal invasion and a Grade 3 tumour invading deeply are both stage 1 and do not carry the same outlook.
Do the ovaries have to be removed for stage 1 endometrial cancer?
In most cases they are removed along with the fallopian tubes, because the ovaries are a possible site of spread and because they continue producing the oestrogen that drove the tumour. In women who are already past the menopause this adds little cost. In younger women it is a genuine decision, because removing the ovaries causes immediate surgical menopause with long-term consequences for bone and cardiovascular health, and there are selected situations in which retaining them is considered. It should be an explicit conversation before the operation rather than something discovered afterwards. Whatever is decided, managing the consequences is part of the care that follows.
How was my stage 1 confirmed if it was based on the surgery?
This is a common source of confusion, because women are often given a provisional stage before the operation and a definitive one afterwards. Imaging — usually MRI — estimates how deeply the tumour has invaded the muscle wall and looks for enlarged nodes, and that produces a working stage used to plan the surgery. But imaging cannot measure invasion precisely and cannot detect small deposits in normal-sized nodes. The definitive stage comes from the pathologist examining the removed uterus and any sampled nodes. Stages are revised in both directions after surgery, and so occasionally is the grade. Decisions about treatment after surgery are made on the final pathology.
Medical disclaimer: This page explains FIGO stage 1 endometrial cancer in general terms and is reviewed by a CION oncologist, following the FIGO staging system and current NCCN and ESGO–ESTRO–ESP guidance. Survival figures quoted are drawn from US SEER registry data, describe large groups of women diagnosed some years ago, and do not predict the outcome for any individual. Indian registry data for endometrial cancer specifically is limited, and we do not publish a CION endometrial survival figure for that reason. Treatment decisions should be made with the oncology team holding your full pathology.